NL302572A - - Google Patents
Info
- Publication number
- NL302572A NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
- Authority
- NL
- Netherlands
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5790262 | 1962-12-27 | ||
| JP6427663 | 1963-10-29 | ||
| JP5741963 | 1963-10-29 | ||
| JP6250163 | 1963-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL302572A true NL302572A (cg-RX-API-DMAC10.html) |
Family
ID=27463499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL302572D NL302572A (cg-RX-API-DMAC10.html) | 1962-12-27 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE641880A (cg-RX-API-DMAC10.html) |
| FR (1) | FR3150M (cg-RX-API-DMAC10.html) |
| GB (1) | GB1080599A (cg-RX-API-DMAC10.html) |
| LU (1) | LU45106A1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL302572A (cg-RX-API-DMAC10.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2495608A1 (fr) * | 1980-12-04 | 1982-06-11 | Morelle Jean | Nouveaux derives de l'acide aspartique et leurs usages |
| EA018007B1 (ru) | 2004-11-26 | 2013-04-30 | Ю Си Эл БИЗНЕС Пи Эл Си | Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии |
| KR101975726B1 (ko) | 2009-04-03 | 2019-05-07 | 오세라 테라퓨틱스, 아이엔씨. | Ｌ-오르니틴 페닐 아세테이트, 및 이의 제조방법 |
| US20120157526A1 (en) | 2009-06-08 | 2012-06-21 | Ucl Business Plc | Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| CN103502203B (zh) | 2010-10-06 | 2016-09-07 | 欧塞拉治疗有限公司 | 制备l-鸟氨酸苯基乙酸盐的方法 |
| EP3685841A1 (en) | 2014-11-24 | 2020-07-29 | Ucl Business Ltd | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies |
| CA2995823A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| WO2018208677A1 (en) | 2017-05-11 | 2018-11-15 | Ocera Therapeutics, Inc. | Processes of making l-ornithine phenylacetate |
| CN107540413A (zh) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法 |
-
0
- NL NL302572D patent/NL302572A/xx unknown
-
1963
- 1963-12-23 GB GB50695/63A patent/GB1080599A/en not_active Expired
- 1963-12-23 LU LU45106D patent/LU45106A1/xx unknown
- 1963-12-26 FR FR958559A patent/FR3150M/fr not_active Expired
- 1963-12-27 BE BE641880A patent/BE641880A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1080599A (en) | 1967-08-23 |
| BE641880A (cg-RX-API-DMAC10.html) | 1964-04-16 |
| LU45106A1 (cg-RX-API-DMAC10.html) | 1964-02-24 |
| FR3150M (fr) | 1965-02-22 |